ARIZONA SONORAN COPPER (H6F) - Net Assets
Based on the latest financial reports, ARIZONA SONORAN COPPER (H6F) has net assets worth €201.75 Million EUR (≈ $235.87 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€333.49 Million ≈ $389.88 Million USD) and total liabilities (€131.73 Million ≈ $154.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check H6F strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €201.75 Million |
| % of Total Assets | 60.5% |
| Annual Growth Rate | 50.45% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 36.86 |
ARIZONA SONORAN COPPER - Net Assets Trend (2021–2025)
This chart illustrates how ARIZONA SONORAN COPPER's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see H6F stock market capitalisation.
Annual Net Assets for ARIZONA SONORAN COPPER (2021–2025)
The table below shows the annual net assets of ARIZONA SONORAN COPPER from 2021 to 2025. Also explore H6F shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €225.84 Million ≈ $264.03 Million |
+115.89% |
| 2024-12-31 | €104.61 Million ≈ $122.30 Million |
+23.73% |
| 2023-12-31 | €84.55 Million ≈ $98.84 Million |
+28.14% |
| 2022-12-31 | €65.98 Million ≈ $77.14 Million |
+49.69% |
| 2021-12-31 | €44.08 Million ≈ $51.53 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ARIZONA SONORAN COPPER's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2651500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €272.32 Million | 120.58% |
| Total Equity | €225.84 Million | 100.00% |
ARIZONA SONORAN COPPER Competitors by Market Cap
The table below lists competitors of ARIZONA SONORAN COPPER ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Scope Metals Group Ltd
TA:SCOP
|
$1.05 Billion |
|
EmbedWay Tech(Shanghai)Corp
SHG:603496
|
$1.05 Billion |
|
Neo Performance Materials Inc
TO:NEO
|
$1.05 Billion |
|
Safety Insurance Group Inc
NASDAQ:SAFT
|
$1.05 Billion |
|
Cangzhou Mingzhu Plastic Co Ltd
SHE:002108
|
$1.05 Billion |
|
Telia Lietuva AB
F:ZWS
|
$1.05 Billion |
|
Mivtach Shamir
TA:MISH
|
$1.05 Billion |
|
ZEAL Network SE
XETRA:TIMA
|
$1.05 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ARIZONA SONORAN COPPER's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 104,609,000 to 225,837,000, a change of 121,228,000 (115.9%).
- Net loss of 4,965,000 reduced equity.
- New share issuances of 120,821,000 increased equity.
- Other factors increased equity by 5,372,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-4.96 Million | -2.2% |
| Share Issuances | €120.82 Million | +53.5% |
| Other Changes | €5.37 Million | +2.38% |
| Total Change | €- | 115.89% |
Book Value vs Market Value Analysis
This analysis compares ARIZONA SONORAN COPPER's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 8.05x to 4.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.62 | €5.01 | x |
| 2022-12-31 | €0.74 | €5.01 | x |
| 2023-12-31 | €0.78 | €5.01 | x |
| 2024-12-31 | €0.77 | €5.01 | x |
| 2025-12-31 | €1.08 | €5.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ARIZONA SONORAN COPPER utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.54x
- Recent ROE (-2.20%) is above the historical average (-11.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -29.63% | 0.00% | 0.00x | 1.23x | €-17.47 Million |
| 2022 | -10.79% | 0.00% | 0.00x | 1.05x | €-13.72 Million |
| 2023 | -8.27% | 0.00% | 0.00x | 1.35x | €-15.44 Million |
| 2024 | -7.11% | 0.00% | 0.00x | 1.29x | €-17.90 Million |
| 2025 | -2.20% | 0.00% | 0.00x | 1.54x | €-27.55 Million |
Industry Comparison
This section compares ARIZONA SONORAN COPPER's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ARIZONA SONORAN COPPER (H6F) | €201.75 Million | -29.63% | 0.65x | $1.05 Billion |
| Covestro AG (1COV) | $1.79 Billion | 15.22% | 4.82x | $11.10 Billion |
| CENTESSA PHARMACEUTICALS (260) | $491.55 Million | 0.00% | 0.28x | $5.35 Billion |
| 2invest AG (2INV) | $63.16 Million | 2.50% | 0.02x | $70.69 Million |
| COINSHARES I. LS-000247 (3TW) | $304.77 Million | 19.41% | 10.42x | $472.53 Million |
| Adaptimmune Therapeutics plc (473A) | $166.14 Million | -43.08% | 0.41x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.44 Million | -21.74% | 0.28x | $214.86K |
| GENOR BIOPHARMA DL-00002 (67N0) | $2.49 Billion | -34.70% | 0.15x | $93.97 Million |
| BENO Holding AG (BENH) | $20.66 Million | 13.94% | 3.37x | $79.56K |
| Biotest Aktiengesellschaft (BIO) | $307.61 Million | 12.84% | 1.06x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $476.90 Million | -0.99% | 1.32x | $656.94 Million |
About ARIZONA SONORAN COPPER
Arizona Sonoran Copper Company Inc. engages in the development, mining, and exploration of copper assets. The company develops the Cactus Mine Project in Arizona for copper cathode production. Its project activities include mine redevelopment, copper exploration, mineral resource and reserve evaluation, technical reporting, and operational planning. Arizona Sonoran Copper Company Inc. was formerl… Read more